|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―May―15 |
Innovation landscape in nanobiosensors for COVID-19 detection and future implications for a resilient Global Health Security |
Abhijit Poddar, S. R. Rao |
2 |
[GO] |
2025―Apr―05 |
Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2 |
Namrata Prashar, Saharuddin Bin Mohammed, N. S. Raja, Habeeb Shaik Mohideen |
3 |
[GO] |
2024―Aug―25 |
Structural insights into Furin enzyme inhibition to block SARS-CoV-2 spike protein cleavage: an in-silico approach |
Ramakrishnan Jaganathan, Poomani Kumaradhas |
4 |
[GO] |
2024―Aug―06 |
In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2 |
Gaurav Sharma, Prateek Paul, Ananya Dviwedi, Parneet Kaur, Pradeep Kumar, V. Kumar Gupta, et al. (+2) Saurav Bhaskar Saha, Saurabh Kulshrestha |
5 |
[GO] |
2024―Apr―09 |
Wastewater treatment from a science faculty during the COVID-19 pandemic by using ammonium-oxidising and heterotrophic bacteria |
Lucas D. Pedroza-Camacho, Paula A. Ospina-Sánchez, Felipe A. Romero-Perdomo, Nury G. Infante-González, Diana M. Paredes-Céspedes, Balkys Quevedo-Hidalgo, et al. (+3) Viviana Gutiérrez-Romero, Claudia M. Rivera-Hoyos, Aura M. Pedroza-Rodríguez |
6 |
[GO] |
2023―Aug―31 |
In silico guided screening of active components of C. lanceolata as 3-chymotrypsin-like protease inhibitors of novel coronavirus |
Ganesh Sharma, Neeraj Kumar, Chandra Shekhar Sharma, Shashank Shekher Mishra |
7 |
[GO] |
2023―Aug―30 |
Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity |
Ritika Khatri, Bharat Lohiya, Gurleen Kaur, Vikas Maithil, Abhishek Goswami, Debapriyo Sarmadhikari, et al. (+2) Shailendra Asthana, Sweety Samal |
8 |
[GO] |
2023―Aug―14 |
De novo design of bioactive phenol and chromone derivatives for inhibitors of Spike glycoprotein of SARS-CoV-2 in silico |
Joan Petrus Oliveira Lima, Aluísio Marques da Fonseca, Gabrielle Silva Marinho, Matheus Nunes da Rocha, Emanuelle Machado Marinho, Helcio Silva dos Santos, et al. (+4) Rafael Melo Freire, Emmanuel Silva Marinho, Pedro de Lima-Neto, Pierre Basílio Almeida Fechine |
9 |
[GO] |
2023―Jul―25 |
A novel monospecific tetravalent IgG1-(scFv)2 version shown enhanced neutralizing and Fc-mediated effector functions against SARS-CoV-2 |
Zhang-zhao Gao, Jing-yu Jiao, Ya-qiong Zhou, Jian Qi, Shan-shan Zhu, Jing-ya Xu, et al. (+2) Lei Nie, Hai-bin Wang |
10 |
[GO] |
2023―Jun―11 |
An overview of opportunistic fungal infections associated with COVID-19 |
Navidita Kangabam, V. Nethravathy |
11 |
[GO] |
2023―May―13 |
In-silico study: docking simulation and molecular dynamics of peptidomimetic fullerene-based derivatives against SARS-CoV-2 Mpro |
Noha A. Saleh |
12 |
[GO] |
2023―Mar―26 |
Deciphering molecular mechanisms of SARS-CoV-2 pathogenesis and drug repurposing through GRN motifs: a comprehensive systems biology study |
Marzieh Sameni, Seyed Amir Mirmotalebisohi, Zeinab Dehghan, Raziyeh Abooshahab, Yalda Khazaei-Poul, Maryam Mozafar, Hakimeh Zali |
13 |
[GO] |
2023―Jan―05 |
Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2 |
Ananya Chugh, Ishita Sehgal, Nimisha Khurana, Kangna Verma, Rajan Rolta, Pranjal Vats, et al. (+6) Deeksha Salaria, Olatomide A. Fadare, Oladoja Awofisayo, Anita Verma, Rajendra Phartyal, Mansi Verma |
14 |
[GO] |
2022―Dec―16 |
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2 |
Udit Chaube, Bhumika D. Patel, Hardik G. Bhatt |
15 |
[GO] |
2022―Dec―11 |
Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review |
Sudhanarayani S. Rao, Krupakar Parthasarathy, Vignesh Sounderrajan, K. Neelagandan, Pradeep Anbazhagan, Vaishnavi Chandramouli |
16 |
[GO] |
2022―Nov―07 |
Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics |
José Ednésio da Cruz Freire, José Edvar Monteiro Júnior, Daniel Pascoalino Pinheiro, Grayce Ellen da Cruz Paiva Lima, Camila Lopes do Amaral, Victor Rezende Veras, et al. (+8) Mayara Ponte Madeira, Erika Bastos Lima Freire, Renan Galvão Ozório, Virgínia Oliveira Fernandes, Ana Paula Dias Rangel Montenegro, Raquel Carvalho Montenegro, Jeová Keny Baima Colares, Renan Magalhães Montenegro Júnior |
17 |
[GO] |
2022―Oct―15 |
Development of CD163 receptor-based enzyme-linked immunosorbent assay for diagnosis of porcine reproductive and respiratory syndrome virus |
Rajib Deb, Ajay Kumar Yadav, Gyanendra Singh Sengar, Joyshikh Sonowal, D. Lalita, Seema Rani Pegu, et al. (+8) Indra Singh, Ningthoukhongjam Linda, Pranab Jyoti Das, Satish Kumar, Prasanna Pal, Souvik Paul, Swaraj Rajkhowa, Vivek Kumar Gupta |
18 |
[GO] |
2022―Oct―13 |
A comprehensive mini-review on amyloidogenesis of different SARS-CoV-2 proteins and its effect on amyloid formation in various host proteins |
Prakriti Seth, Nandini Sarkar |
19 |
[GO] |
2022―Sep―21 |
Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach |
Navya B. Prabhu, Chigateri M. Vinay, Kapaettu Satyamoorthy, Padmalatha S. Rai |
20 |
[GO] |
2022―Aug―23 |
Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses |
Avinash Kumar, Ekta Rathi, Suvarna Ganesh Kini |
21 |
[GO] |
2022―Aug―17 |
Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection |
Sonu Kumar, Debrupa Dutta, Velayutham Ravichandiran, Soumi Sukla |
22 |
[GO] |
2022―Aug―02 |
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2 |
Sonal Garg, Nisha Raj, Asha Lukose, Deepti Jamwal, Hilal Ahmed Parray, Sandeep Kumar, et al. (+9) Samridhi Dhyani, Kamini Jakhar, Sudipta Sonar, Mahima Tiwari, Shailendra Mani, Sankar Bhattacharyya, Chandresh Sharma, Tripti Shrivastava, Rajesh Kumar |
23 |
[GO] |
2022―Mar―03 |
Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q |
Shahzaib Ahamad, Kanipakam Hema, Shahnawaz Ahmad, Vijay Kumar, Dinesh Gupta |
24 |
[GO] |
2021―Dec―12 |
COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review |
Faizan Zarreen Simnani, Dibyangshee Singh, Ramneet Kaur |
25 |
[GO] |
2021―Dec―06 |
COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis |
Rachel Samson, Mahesh Dharne |
26 |
[GO] |
2021―Jun―28 |
Use of nanotechnology in combating coronavirus |
Saee Gharpure, Balaprasad Ankamwar |
27 |
[GO] |
2021―Apr―25 |
Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2 |
Aanchal Mathur, Sibi Raj, Niraj Kumar Jha, Saurabh Kumar Jha, Brijesh Rathi, Dhruv Kumar |
28 |
[GO] |
2021―Mar―27 |
A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing |
S. Udhaya Kumar, N. Madhana Priya, S. R. Nithya, Priyanka Kannan, Nikita Jain, D. Thirumal Kumar, et al. (+4) R. Magesh, Salma Younes, Hatem Zayed, C. George Priya Doss |
29 |
[GO] |
2021―Feb―22 |
Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α |
Munikumar Manne, Giridhar Goudar, Seshadri Reddy Varikasuvu, Mahadev C. Khetagoudar, Hema Kanipakam, Pradeep Natarajan, et al. (+7) Muni Divya Ummiti, Vijay Aravind Yenagi, Sridhar Chinthakindi, Prakash Dharani, Durga Sai Sri Thota, Sameer Patil, Vijaylaxmi Patil |
30 |
[GO] |
2021―Feb―09 |
Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology |
Pukar Khanal, Taaza Duyu, B. M. Patil, Yadu Nandan Dey, Ismail Pasha, Rohini S. Kavalapure, et al. (+2) Sharad Chand, Shailendra Gurav |
31 |
[GO] |
2021―Feb―01 |
Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection |
Tirthankar Koley, Shivani Madaan, Sanghati Roy Chowdhury, Manoj Kumar, Punit Kaur, Tej Pal Singh, Abdul S. Ethayathulla |
32 |
[GO] |
2021―Jan―25 |
Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective |
Yashwant Kumar Ratre, Namrata Kahar, L. V. K. S. Bhaskar, Antaripa Bhattacharya, Henu Kumar Verma |
33 |
[GO] |
2021―Jan―24 |
Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach |
Sanjay Kumar Singh, Atul Kumar Upadhyay, M. Sudhakara Reddy |
34 |
[GO] |
2021―Jan―22 |
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19) |
Salma Bessalah, Samira Jebahi, Naceur Mejri, Imed Salhi, Touhami Khorchani, Mohamed Hammadi |
35 |
[GO] |
2021―Jan―13 |
Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis |
Shalja Verma, Anand Kumar Pandey |
36 |
[GO] |
2021―Jan―12 |
Smart technologies driven approaches to tackle COVID-19 pandemic: a review |
Hameed Khan, K. K. Kushwah, Saurabh Singh, Harshika Urkude, Muni Raj Maurya, Kishor Kumar Sadasivuni |
37 |
[GO] |
2021―Jan―12 |
In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2 |
Shridhar Hiremath, H. D. Vinay Kumar, M. Nandan, M. Mantesh, K. S. Shankarappa, V. Venkataravanappa, et al. (+2) C. R. Jahir Basha, C. N. Lakshminarayana Reddy |
38 |
[GO] |
2021―Jan―12 |
Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches |
Ratnadeep Saha, Pratik Ghosh, V. L. S. Prasad Burra |
39 |
[GO] |
2021―Jan―09 |
Recent biotechnological advances as potential intervention strategies against COVID-19 |
Naun Lobo-Galo, Juan-Carlos Gálvez-Ruíz, Ana P. Balderrama-Carmona, Norma P. Silva-Beltrán, Eduardo Ruiz-Bustos |
40 |
[GO] |
2020―Nov―26 |
Probiotics in the prophylaxis of COVID-19: something is better than nothing |
Kushal Gohil, Rachel Samson, Syed Dastager, Mahesh Dharne |
41 |
[GO] |
2020―Nov―11 |
Immunotherapeutics for Covid-19 and post vaccination surveillance |
N. S. Sampath Kumar, Anjani Devi Chintagunta, S. P. Jeevan Kumar, Sharmili Roy, Mahesh Kumar |
42 |
[GO] |
2020―Oct―21 |
In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2 |
El Mehdi Bouricha, Mohammed Hakmi, Jihane Akachar, Lahcen Belyamani, Azeddine Ibrahimi |
43 |
[GO] |
2020―Oct―19 |
Targeting complement cascade: an alternative strategy for COVID-19 |
Sureshbabu Ram Kumar Pandian, Sankarganesh Arunachalam, Venkataraman Deepak, Selvaraj Kunjiappan, Krishnan Sundar |
44 |
[GO] |
2020―Sep―16 |
An overview of COVID-19 with an emphasis on computational approach for its preventive intervention |
Divya Mishra, Ashish Mishra, Vivek K. Chaturvedi, M. P. Singh |
45 |
[GO] |
2020―Sep―10 |
Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods |
Basavaraj Vastrad, Chanabasayya Vastrad, Anandkumar Tengli |
46 |
[GO] |
2020―Aug―17 |
Investigation on the impacts of COVID-19 quarantine on society and environment: Preventive measures and supportive technologies |
Santhosh Kumar Kumaravel, Ranjith Kumar Subramani, Tharun Kumar Jayaraj Sivakumar, Rajvikram Madurai Elavarasan, Ajayragavan Manavalanagar Vetrichelvan, Annapurna Annam, Umashankar Subramaniam |
47 |
[GO] |
2020―Aug―11 |
Biosensors: frontiers in rapid detection of COVID-19 |
Rachel Samson, Govinda R. Navale, Mahesh S. Dharne |